Yang, Seung Ho <br/><br/>
Metformin treatment reduces temozolomide resistance of glioblastoma cells.  [electronic resource] 

 -  Oncotarget  Nov 2016 
 - 78787-78803 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.12859  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Dacarbazine--analogs & derivatives<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm<br/>Gene Expression Regulation, Neoplastic<br/>Gene Regulatory Networks<br/>Glioblastoma--drug therapy<br/>Humans<br/>Inhibitory Concentration 50<br/>Metformin--pharmacology<br/>Mice, SCID<br/>Neoplasm Invasiveness<br/>SOXB1 Transcription Factors--genetics<br/>Temozolomide<br/>Time Factors<br/>Transcriptome<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays